STOCK TITAN
  1. Home
  2. Sec-filings
  3. BCRX
  4. [8-K] – BIOCRYST PHARMACEUTICALS INC (BCRX) (CIK 0000882796)

[8-K] – BIOCRYST PHARMACEUTICALS INC (BCRX) (CIK 0000882796)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BCRX logo
Biocryst Pharmaceuticals Inc

NASDAQ:BCRX

BCRX Rankings

#2337 Ranked by Market Cap
N/A Ranked by Dividends
#20 Top Loser

BCRX Latest News

Oct 14, 2025
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
Oct 3, 2025
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 1, 2025
BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business
Sep 3, 2025
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 21, 2025
BioCryst to Present at Upcoming Investor Conference

BCRX Latest SEC Filings

Oct 14, 2025
[425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Oct 14, 2025
[425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Oct 1, 2025
[8-K] BIOCRYST PHARMACEUTICALS INC Reports Material Event
Sep 19, 2025
[SCHEDULE 13G] BIOCRYST PHARMACEUTICALS INC SEC Filing
Sep 19, 2025
[SCHEDULE 13G] BIOCRYST PHARMACEUTICALS INC SEC Filing

BCRX Stock Data

1.52B
207.42M
1.26%
95.59%
13.09%
Drug Manufacturers - Specialty & Generic
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM